Quantum-Si incorporated (QSI) Stock Analysis & Investment Frameworks
Quantum-Si incorporated (QSI) stock analysis on Invetso. Review Quantum-Si incorporated’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Quantum-Si incorporated Company Overview
- Exchange: NASDAQ Global Market
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
Quantum-Si incorporated Key Financial Metrics
- Market Cap: $264.60M
- Revenue: $2.44M
- ROE: -44.72%
- ROIC: -57.90%
- Dividend Yield: N/A
About Quantum-Si incorporated
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
Quantum-Si incorporated Investment Frameworks
Invetso analyzes Quantum-Si incorporated (QSI) across the following frameworks:
- Quantum-Si incorporated 10Y Growth Potential
- Quantum-Si incorporated Scenario Analysis
- Quantum-Si incorporated Risks & Opportunities
- Quantum-Si incorporated Economic Moat
- Quantum-Si incorporated Business Model
- Quantum-Si incorporated Management
- Quantum-Si incorporated SWOT Analysis
- Quantum-Si incorporated Porter's 5 Forces
- Quantum-Si incorporated PESTLE Analysis
- Quantum-Si incorporated ESG Analysis